Ivermectin

Open Forum Infectious Diseases, ofab358, https://doi.org/10.1093/ofid/ofab358

By late last year with mounting numbers of ivermectin clinical trials, mostly from low-and middle-income countries (LMICs), the potential for ivermectin as a treatment for COVID-19 gained significant movement. Key studies from McMaster’s TOGETHER study to a meta-analysis authored by Dr. Andrew Hill, affiliated with the University of Liverpool, and Unitaid—affiliated organization of the World Health Organization (WHO)—were to pave the way for use of the low cost, repurposed drug. But due to a purported under-dosing in the TOGETHER study and some questionable last-minute changes in the Unitaid-sponsored Hill meta-analysis, the pro-ivermectin consensus went south. With pharmaceutical companies developing vaccines in support of a universal vaccination program, any low-cost alternatives for early care weren’t well supported by any influencers in the medical establishments of North America and Europe. Additional companies such as Gilead, Merck, AstraZeneca, Regeneron, and Pfizer were busy securing in the aggregate billions of taxpayer dollars to develop antivirals and monoclonal antibodies. The market for early-stage antiviral care for mild-to-moderate COVID-19 involves big stakes, and key industry players know it. The potential market could be worth $10 billion per year—clearly, blockbuster-plus territory. The vaccines could produce $100 billion in the first two years of the pandemic for Pfizer—just unprecedented amounts of money. Did a combination of well-intended vaccination and advanced therapy programs coupled with industry interests and regulatory capture lead to the sabotage of ivermectin initiatives? If true, does this implicate an entire drug development system that became painfully obvious during the first modern pandemic? If this is the case, then Andrew Hill becomes a poster child for bias, questionable ethics, and possibly even corruption at the highest levels. On the other hand, was it just a system working the way it has evolved to work?

Ivermectin is seen as a repeat of hydroxychloroquine and not to be taken seriously. Belief in it, worthy only of derision.

'This is a major breakthrough for the people of SA as we believe that Ivermectin can assist in this pandemic', says Bongani Luthuli.

Last week Project Veritas revealed that US Military documents contradicted Fauci’s sworn testimony about gain-of-function.  Since then six Congressional Members have sent letters to the CDC, S…

This is an updated version of an article that was first published in July 2021 A recent peer reviewed meta-analysis evaluating ivermectin ...

No legal prohibition authorized or justified hospitals to withhold the drug from dying patients. Let the lawsuits begin.

In this Buffalo hospital room, a grandmother led the global fight for the drug that would ave her life and end the pandemic.

My chronology of the Disinformation tactics deployed to paint ivermectin as an ineffective horse dewormer against Covid. Largely taken from the ever-evolving keynote lecture I give at conferences

In the wake of the FLCCC press conference, Senate Testimony and review paper retraction, suddenly Merck fires the first public salvo in the Disinformation war by posting brazen lies on their website.

The final phases of the Disinformation war on ivermectin kicks into high gear with the launch of the "Horse Dewormer" public relations campaign followed by the publication of Pharma corrupted trials.

Buy War on Ivermectin: The Medicine That Saved Millions and Could Have Ended the Pandemic by Kory, Pierre, McCarthy, Jenna, Bigtree, del (ISBN: 9781510773868) from Amazon's Book Store. Everyday low prices and free delivery on eligible orders.

(Washington, D.C.) Judicial Watch announced today that it received 254 pages of records from the Department of Health and Human Services (HHS) this included emails of then-Director of the National Institutes of Health (NIH) Francis Collins regarding a British group’s recommendations on the use of Ivermectin to prevent and treat COVID-19.

Covid Care Guidance Protocols for treatments of Covid-19 including ivermectin NOTICE: These protocols are solely for educational purposes regarding potentially beneficial therapies for COVID-19. Never disregard professional medical advice because of something you have read on our website and releases. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment […]

In the UK, the ‘COVID Therapeutics Advisory Panel’ played a critical role in deciding which drugs would be rolled out in the fight against COVID. The panel, we were told, was tasked to “accelerate delivery of large scale trials for COVID-19 treatments”. CTAP were to

Sources in the government said that the decision to replace Hydroxychloroquine (HCQ) with Ivermectin was taken after encouraging results in Agra, where it was used on an experimental basis.